Clinical trial
Long-term Study of Cariprazine in Patients With Schizophrenia
NCT01104792
Study timeline
Study start (actual)2010-05-31Date precision: day
Registry last updated2019-07-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
CariprazineDRUG · verified · RxNorm: cariprazine
Sponsors & collaborators
Forest Laboratorieslead sponsor
Gedeon Richter Ltd.collaborator
Mapped research locations
Saint PetersburgRussia6Little RockArkansas, United States3PhiladelphiaPennsylvania, United States2AtlantaGeorgia, United States2KharkivUkraine2SaratovRussia2Garden GroveCalifornia, United States2BogotáColombia2ChicagoIllinois, United States1St LouisMissouri, United States1San DiegoCalifornia, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01104792 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.